Nana Ping

570 total citations
32 papers, 354 citations indexed

About

Nana Ping is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Nana Ping has authored 32 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Nana Ping's work include Lymphoma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (6 papers) and Acute Myeloid Leukemia Research (5 papers). Nana Ping is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (6 papers) and Acute Myeloid Leukemia Research (5 papers). Nana Ping collaborates with scholars based in China, United States and Pakistan. Nana Ping's co-authors include Yong‐Xiao Cao, Lei Cao, Zhengming Jin, Changju Qu, Xue Xiao, Liqing Kang, Lei Yu, Qian Wu, Yanbing Zhu and Sen Li and has published in prestigious journals such as Blood, PLoS ONE and Genome biology.

In The Last Decade

Nana Ping

26 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nana Ping China 11 125 78 63 57 53 32 354
Alessia Poggi Italy 11 80 0.6× 119 1.5× 36 0.6× 66 1.2× 14 0.3× 22 468
Ana Alonso‐Pérez Spain 9 43 0.3× 125 1.6× 19 0.3× 39 0.7× 19 0.4× 19 329
Xue Qin China 11 43 0.3× 92 1.2× 21 0.3× 19 0.3× 15 0.3× 42 289
Maya Suzuki Japan 9 149 1.2× 106 1.4× 15 0.2× 22 0.4× 21 0.4× 35 359
Huimin Jin China 11 79 0.6× 137 1.8× 24 0.4× 36 0.6× 6 0.1× 29 323
Michael Hollis United States 12 87 0.7× 228 2.9× 11 0.2× 40 0.7× 30 0.6× 26 527
Shaofeng Wang China 12 79 0.6× 168 2.2× 109 1.7× 23 0.4× 14 0.3× 32 506
Benjamin Xiaoyi Li China 6 37 0.3× 67 0.9× 132 2.1× 31 0.5× 17 0.3× 11 301
Manuel O. Jakob Switzerland 10 80 0.6× 135 1.7× 14 0.2× 23 0.4× 12 0.2× 21 464

Countries citing papers authored by Nana Ping

Since Specialization
Citations

This map shows the geographic impact of Nana Ping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nana Ping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nana Ping more than expected).

Fields of papers citing papers by Nana Ping

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nana Ping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nana Ping. The network helps show where Nana Ping may publish in the future.

Co-authorship network of co-authors of Nana Ping

This figure shows the co-authorship network connecting the top 25 collaborators of Nana Ping. A scholar is included among the top collaborators of Nana Ping based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nana Ping. Nana Ping is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaomin, Xiaoxu Liu, Ming Zeng, et al.. (2025). Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia. Neurochemistry International. 188. 106004–106004.
2.
Zhang, Mengli, Judith Hyle, Xiaowen Chen, et al.. (2024). RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome biology. 25(1). 16–16. 3 indexed citations
3.
Qu, Changju, Hailing Liu, Rui Zou, et al.. (2023). P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL. HemaSphere. 7(S3). e918465b–e918465b. 1 indexed citations
4.
5.
6.
Qu, Changju, Rui Zou, Peng Wang, et al.. (2022). Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients. Frontiers in Immunology. 13. 969660–969660. 25 indexed citations
7.
8.
Ping, Nana, Changju Qu, Mengyun Li, et al.. (2022). Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma. Annals of Translational Medicine. 10(6). 298–298. 15 indexed citations
9.
Li, Xuewei, Nana Ping, Yong Wang, et al.. (2021). Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature. Frontiers in Oncology. 10. 584149–584149. 5 indexed citations
10.
Xia, Fan, Hailing Liu, Haizhou Zhang, et al.. (2021). Multiple blood parameters may serve as a warning to immunochemotherapy-related interstitial lung disease in B-cell lymphoma. Annals of Palliative Medicine. 10(9). 9660–9668. 3 indexed citations
11.
12.
Chen, Jingguo, Nana Ping, Mengyi Li, et al.. (2016). The expression of bitter taste receptors in mesenteric, cerebral and omental arteries. Life Sciences. 170. 16–24. 25 indexed citations
13.
Ping, Nana, et al.. (2016). H2S Prevents Cyclosporine A-Induced Vasomotor Alteration in Rats. Cardiovascular Toxicology. 17(3). 287–296. 5 indexed citations
14.
Ping, Nana, Yiting Song, Yihan Xu, et al.. (2016). Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia. Leukemia. 31(1). 195–202. 31 indexed citations
15.
Li, Sen, et al.. (2015). H2S induces vasoconstriction of rat cerebral arteries via cAMP/adenylyl cyclase pathway. Toxicology and Applied Pharmacology. 289(3). 389–396. 23 indexed citations
16.
Yao, Hong, Jinlan Pan, Chunxiao Wu, et al.. (2015). Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22). Molecular Cancer. 14(1). 81–81. 4 indexed citations
17.
Chen, Suning, Nana Ping, Jia Yin, et al.. (2015). Exome Sequencing Identifies Highly Recurrent Somatic GATA2 and CEBPA Mutations in Acute Erythroid Leukemia. Blood. 126(23). 1394–1394. 22 indexed citations
18.
Xiao, Xue, et al.. (2014). An optimal initial tension for rat basilar artery in wire myography. Microvascular Research. 97. 156–158. 8 indexed citations
19.
Ping, Nana, et al.. (2014). The Severe Adverse Reaction to Vitamin K1 Injection Is Anaphylactoid Reaction but Not Anaphylaxis. PLoS ONE. 9(3). e90199–e90199. 34 indexed citations
20.
Qin, Lili, Qinrong Wang, Qian Wang, et al.. (2013). T-SPOT.TB for Detection of Tuberculosis Infection among Hematological Malignancy Patients and Hematopoietic Stem Cell Transplant Recipients. Asian Pacific Journal of Cancer Prevention. 14(12). 7415–7419. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessia Poggi Breakdown of academic impact, for papers by Ana Alonso‐Pérez Breakdown of academic impact, for papers by Xue Qin Breakdown of academic impact, for papers by Maya Suzuki Breakdown of academic impact, for papers by Huimin Jin Breakdown of academic impact, for papers by Michael Hollis Breakdown of academic impact, for papers by Shaofeng Wang Breakdown of academic impact, for papers by Benjamin Xiaoyi Li Breakdown of academic impact, for papers by Manuel O. Jakob
Rankless by CCL
2026